Document Detail


Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison with the standard fixed dose benzodiazepine regimen.
MedLine Citation:
PMID:  22011975     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of the study was to compare symptom-triggered and standard benzodiazepine regimens for the treatment of alcohol withdrawal syndrome in an emergency department clinical decision unit. The authors found that the symptom-triggered approach reduced cumulative benzodiazepine dose and length of stay.
Authors:
Eugene M Cassidy; Iomhar O'Sullivan; Paula Bradshaw; Tariq Islam; Chidozie Onovo
Related Documents :
12384855 - Colonic necrosis and perforation secondary to escherichia coli o157:h7 gastroenteritis ...
11815335 - The incidence and pathology of conjunctival ulceration in behçet's syndrome.
1290235 - Solitary rectal ulcer syndrome.
21572545 - Neuroprotective fractalkine in fetal alcohol syndrome.
11801775 - Factor xiiia-positive dendrocyte rarefaction in ehlers-danlos syndrome, classic type.
9507645 - A syndrome of anaemia, immunodeficiency and peripheral ganglionopathy in fell pony foals.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-19
Journal Detail:
Title:  Emergency medicine journal : EMJ     Volume:  -     ISSN:  1472-0213     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100963089     Medline TA:  Emerg Med J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Psychiatry, Cork University Hospital, Cork, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The emergency first aid responder system model: using community members to assist life-threatening e...
Next Document:  Lorcaserin: An investigational serotonin 2C agonist for weight loss.